
Burning Rock Biotech Limited BNR
€ 14.51
-0.96%
Geschäftsbericht 2021
hinzugefügt 23.12.2023
Burning Rock Biotech Limited Current Ratio 2011-2026 | BNR
Current Ratio Jährlich Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.26 | 11 | 4 | 0.382 | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 11 | 0.382 | 5.16 |
Current Ratio Vierteljährlich Burning Rock Biotech Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 5.26 | - | - | - | 11 | - | - | - | 4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 11 | 4 | 6.75 |
Current Ratio anderer Aktien in der Diagnostik & Forschung
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
2.01 | $ 117.53 | 4.77 % | $ 35.7 B | ||
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
3.75 | $ 20.7 | -1.24 % | $ 1.1 B | ||
|
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
6.01 | $ 1.59 | 1.27 % | $ 2.12 M | ||
|
Castle Biosciences
CSTL
|
7.05 | $ 24.6 | -3.61 % | $ 683 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.69 | $ 26.45 | 0.8 % | $ 20 B | ||
|
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
1.82 | $ 185.39 | 7.58 % | $ 9.19 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
13.4 | $ 14.9 | -1.46 % | $ 451 M | ||
|
Guardant Health
GH
|
0.953 | $ 89.52 | -1.81 % | $ 11.2 B | ||
|
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
2.29 | $ 121.32 | 8.35 % | $ 10 B | ||
|
Illumina
ILMN
|
6.69 | $ 139.07 | -0.22 % | $ 22.1 B | ||
|
Interpace Biosciences
IDXG
|
2.95 | $ 2.01 | 0.4 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
3.23 | $ 2.19 | 1.16 % | $ 5.03 M | ||
|
Lantheus Holdings
LNTH
|
1.96 | $ 85.82 | -2.23 % | $ 5.79 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 257.14 | 1.64 % | $ 21.4 B | ||
|
Medpace Holdings
MEDP
|
1.3 | $ 430.32 | 3.19 % | $ 12.4 B | ||
|
Celcuity
CELC
|
1.27 | $ 141.69 | -2.27 % | $ 6.63 B | ||
|
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
2.09 | $ 5.03 | 1.82 % | $ 466 M | ||
|
NeoGenomics
NEO
|
2.6 | $ 8.86 | -1.56 % | $ 1.13 B | ||
|
Neogen Corporation
NEOG
|
2.51 | $ 9.27 | 1.98 % | $ 2.01 B | ||
|
National Research Corporation
NRC
|
1.12 | $ 18.74 | 2.85 % | $ 419 M | ||
|
Natera
NTRA
|
2.02 | $ 206.77 | -2.26 % | $ 20.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 190.84 | -0.34 % | $ 21.2 B | ||
|
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | ||
|
Exagen
XGN
|
1.43 | $ 3.09 | -0.32 % | $ 66.6 M | ||
|
Precipio
PRPO
|
3.16 | $ 32.37 | 8.99 % | $ 52 M | ||
|
Personalis
PSNL
|
4.02 | $ 5.56 | -5.76 % | $ 329 M |